233 related articles for article (PubMed ID: 25691085)
1. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.
Abouharb S; Moulder S
Curr Oncol Rep; 2015 Mar; 17(3):431. PubMed ID: 25691085
[TBL] [Abstract][Full Text] [Related]
2. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.
Vranic S; Stafford P; Palazzo J; Skenderi F; Swensen J; Xiu J; Spetzler D; Gatalica Z
Clin Breast Cancer; 2020 Aug; 20(4):326-331.e1. PubMed ID: 32197944
[TBL] [Abstract][Full Text] [Related]
3. Management and Outcomes in Metaplastic Breast Cancer.
Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations in metaplastic breast carcinoma.
Cooper CL; Karim RZ; Selinger C; Carmalt H; Lee CS; O'Toole SA
J Clin Pathol; 2013 Jun; 66(6):522-8. PubMed ID: 23372178
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic breast carcinoma: Current therapeutic approaches and novel targeted therapies.
Drekolias D; Mamounas EP
Breast J; 2019 Nov; 25(6):1192-1197. PubMed ID: 31250492
[TBL] [Abstract][Full Text] [Related]
6. Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
Salemis NS
Breast Dis; 2018; 37(3):169-175. PubMed ID: 29504519
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic carcinoma of the breast: mammographic appearance with pathologic correlation.
Patterson SK; Tworek JA; Roubidoux MA; Helvie MA; Oberman HA
AJR Am J Roentgenol; 1997 Sep; 169(3):709-12. PubMed ID: 9275883
[TBL] [Abstract][Full Text] [Related]
8. Aggressive Metaplastic Carcinoma of the Breast with Osteoclastic Giant Cells.
Khong K; Zhang Y; Tomic M; Lindfors K; Aminololama-Shakeri S
J Radiol Case Rep; 2015 Sep; 9(9):11-9. PubMed ID: 26629304
[TBL] [Abstract][Full Text] [Related]
9. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
Merino D; Lok SW; Visvader JE; Lindeman GJ
Oncogene; 2016 Apr; 35(15):1877-87. PubMed ID: 26257067
[TBL] [Abstract][Full Text] [Related]
10. Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.
Zhou N; Liu C; Hou H; Zhang C; Liu D; Wang G; Liu K; Zhu J; Lv H; Li T; Zhang X
Oncotarget; 2016 Nov; 7(44):72373-72379. PubMed ID: 27738308
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets.
Tenhagen M; van Diest PJ; Ivanova IA; van der Wall E; van der Groep P
Endocr Relat Cancer; 2012 Aug; 19(4):R115-29. PubMed ID: 22508544
[TBL] [Abstract][Full Text] [Related]
12. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic signaling, a novel target for cancer therapy?
Schuller HM
Oncotarget; 2010 Nov; 1(7):466-469. PubMed ID: 21317444
[No Abstract] [Full Text] [Related]
14. Therapeutic strategies for breast cancer based on histological type.
Akiyama F; Horii R
Breast Cancer; 2009; 16(3):168-72. PubMed ID: 19479319
[TBL] [Abstract][Full Text] [Related]
15. Spindle cell carcinoma of the breast: a case report and discussion.
Nahleh Z; Ebrahim V; Guerrero R; Gaur S; Ayyappan A; Padilla O
Breast Dis; 2011; 33(3):115-9. PubMed ID: 22668813
[TBL] [Abstract][Full Text] [Related]
16. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
17. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease.
Takala S; Heikkilä P; Nevanlinna H; Blomqvist C; Mattson J
Breast J; 2019 May; 25(3):418-424. PubMed ID: 30925636
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations.
Reddy TP; Rosato RR; Li X; Moulder S; Piwnica-Worms H; Chang JC
Breast Cancer Res; 2020 Nov; 22(1):121. PubMed ID: 33148288
[TBL] [Abstract][Full Text] [Related]
20. Metaplastic carcinoma of the breast.
Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
